A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip
NCT ID: NCT02163603
Last Updated: 2016-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2 participants
OBSERVATIONAL
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)
NCT02633904
A New Pelvic Osteotomy Method for Open Reduction
NCT04007016
Closed Reduction With Anesthesia and no Anesthesia for Developmental Dislocation of the Hip < 6 Months
NCT03096470
Mid-term Results of Epiphyseal Transfer for Hip Post Septic Epiphyseal Loss
NCT07321418
Study of Prognostic Factors of the Distal Epiphysis of the Tibia Fracture Prognosis
NCT02723825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pelvic osteotomy
Pelvic osteotomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pelvic osteotomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Patients are complicated with mental, neurological disorders (such as hypoxic-ischemic encephalopathy, epilepsy and dementia) or significant barriers to growth.
* Patients are complicated with cerebral palsy, multiple joint contractures disease.
* Children are complicated with dysfunction of liver and kidney , blood disorders, immune deficiency disease and ECG abnormalities.
* Parents refused further treatment.
1 Year
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Hunan Children's Hospital
OTHER_GOV
Shenzhen Children's Hospital
OTHER_GOV
Foshan Hospital of Traditional Chinese Medicine
OTHER
Wuhan Women and Children's Medical Center
OTHER
Hongwen Xu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hongwen Xu
Guangzhou Women and Children's Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GuangzhouWCMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.